MD&A · 2024
In this section4 topics
Overview of Operations
Overview of Operations
Techno Medical Public Company Limited operates as a distributor of medical devices and equipment. The company imports medical devices and equipment from leading global manufacturers to be distributed to hospitals in Thailand, including government hospitals, private hospitals, clinics, and medical personnel. The products that the company distributes are modern medical devices and equipment that meet international standards. These products are divided into two groups based on their usage. In 2023, the subsidiary (TM Nursing Care Co., Ltd., later renamed The Parents Co., Ltd.) opened a health innovation center for longevity and elderly care, generating revenue from care-related services. Therefore, the revenue is classified into 3 groups as follows:
1. Disposable and Supplies Group
2. Medical Equipment and Instrument Group
3. Nursing Care Services
Considering the overall operating results of the company from 2022 to 2024, the company's sales revenue has increased with an average growth rate (Compound Annual Growth Rate: CAGR) throughout the period. The growth rate is 6.10 percent. However, considering sales in 2022, sales decreased due to lower demand for products from the hand sanitizer gel and disinfectant groups. The Antigen Test Kit group also experienced a decrease in demand following the improving COVID-19 situation. This is also due to the increasing variety of products in the market. The company has expanded its distribution of specialized medical devices and equipment. Coupled with the company being an exclusive distributor of medical devices and equipment, the company has gained trust in the quality of its products and is well-known among customers in the medical device and equipment market. Meanwhile, sales in 2023 increased due to higher sales of disposable operating room products and blood bank products. The company has expanded its market to new hospitals since the second quarter of 2022. The subsidiary (The Parents Co., Ltd.) opened a health rehabilitation and elderly care service in 2023, resulting in an increase in revenue from care-related services of 10.25 million baht. Sales in 2024 increased significantly due to higher sales of disposable operating room products and blood bank products. The company has expanded its market to new hospitals since the second quarter of 2022. The subsidiary (The Parents Co., Ltd.) opened a health rehabilitation and elderly care service in 2026, resulting in an increase in revenue from care-related services to 15.46 million baht in 2024.
The company had total revenue in 2022, 2023, and 2024 of 649.73 million baht, 702.67 million baht, and 730.45 million baht, respectively. This can be broken down into sales revenue of 642.86 million baht, 696.02 million baht, and 725.18 million baht, representing 98.94 percent, 99.05 percent, and 99.28 percent of total revenue, respectively. Other income was 2.18 million baht, 0.99 million baht, and 0.83 million baht, representing 0.34 percent, 0.14 percent, and 0.11 percent of total revenue, respectively.
Operating Results & Financial Condition
Operating Results & Profitability
Revenue from sales by product type
The company's revenue from sales can be divided by product type into 3 groups: equipment and consumables, medical equipment and instruments, and health rehabilitation and care services.
1. Revenue from disposables and supplies
In 2022, 2023, and 2024, revenue from sales of equipment and consumables totaled 612.93 million baht, 657.20 million baht, and 699.30 million baht, representing 95.34 percent, 94.43 percent, and 96.43 percent of sales revenue, respectively. In 2023, sales increased due to increased sales of disposable operating room products and blood bank products. The company expanded its market to new hospitals since the second quarter of 2022, and continued marketing for new products resulted in increased sales, such as Alcohol ball products. Revenue in 2023 increased significantly compared to 2022, where sales of equipment and consumables increased due to demand for products used in infection control, including disinfectants and gloves, which remained in demand despite the less severe COVID-19 outbreak situation. However, operating room units have started to perform surgeries as usual, especially for products used in the operating room, such as devices used to suction blood and secretions from the surgical site, surgical drapes, intravenous fluid administration devices, suction catheters, gloves, and body waste bags, etc. In 2024, sales increased from disposable operating room products and blood bank products as hospitals were able to resume normal surgical services, and continued market expansion resulted in continued sales growth.
2. Revenue from sales of medical equipment and instrument
In 2022, 2023, and 2024, revenue from the medical equipment and instruments group totaled 29.94 million baht, 28.56 million baht, and 10.42 million baht, or representing 4.66 percent, 4.10 percent, and 1.44 percent of sales revenue, respectively. The decrease in revenue was due to the termination of being a distributor for one company. However, the company has considered selecting new manufacturers and is in the process of accelerating continuous marketing to bring back sales in the medical equipment group.
3. Revenue from Nursing Care services
In 2023, the subsidiary (The Parents Company Limited) launched The Parents elderly care center, with an average of 20 service users per month. In 2024, the average number of service users increased to 30 per month, resulting in an increase in service revenue from 10.25 million baht in 2023 to 15.46 million baht in 2024.
Other income
The company's other income in 2022 – 2024 amounted to 2.18 million baht, 0.99 million baht, and 0.83 million baht, or representing an other income to total revenue ratio of 0.34 percent, 0.14 percent, and 0.11 percent, respectively. The company's other income mainly consisted of gains from the sale of the company's idle assets. Other income in 2023 compared to 2022 decreased by 1.19 million baht or -54.59 percent due to the company having a gain on the sale of vehicles that reached the end of their useful life of 0.70 million baht and financial assistance from the Department of Labor from the COVID-19 outbreak of 0.31 million baht in 2022, and interest income from fixed deposits with banks. Other income in 2024 compared to 2023 decreased by 0.16 million baht or 16.16 percent due to the company having only interest income from fixed deposits with banks.
Cost of sales and cost of service
Cost of sales is the company's main expense as it is a trading business. The main cost of sales is the cost of purchased goods. In 2022 – 2024, the company had a cost of sales of 414.33 million baht, 465.50 million baht, and 492.31 million baht, or representing 63.77 percent, 66.25 percent, and 67.40 percent of sales revenue, respectively.
In 2022, the company had a cost of sales of 414.33 million baht, representing a cost of sales to sales ratio of 63.77 percent, which decreased by 3.99 million baht compared to the same period of 2021, which correlated with the decreased sales volume. However, the distributor adjusted the cost price up from the original price by 5 percent to 10 percent in 2021, resulting in a slight decrease in the cost of sales compared to the decrease in sales. The subsidiary began recording depreciation of equipment in patient rooms as cost of sales.
In 2023, the company had a cost of sales of 465.50 million baht, representing a cost of sales to sales ratio of 66.25 percent, which increased by 51.17 million baht compared to the same period of 2022, which correlated with the increased sales volume. The subsidiary recorded depreciation of equipment in patient rooms as cost of sales and began depreciating the inpatient building in January 2023, resulting in an increase in cost of sales.
In 2024, the company had a cost of sales of 492.31 million baht, representing a cost of sales to sales ratio of 67.40 percent, which increased by 26.81 million baht compared to the same period of 2023, which correlated with the increased sales volume. The subsidiary recorded depreciation of equipment in patient rooms as cost of sales and began depreciating the inpatient building in January 2023, resulting in an increase in cost of sales.
Distribution costs and administrative expenses
Distribution costs
In 2022 – 2024, distribution costs were 94.90 million baht, 90.64 million baht, and 100.07 million baht, respectively, or representing a distribution cost to total revenue ratio of 14.61 percent, 12.90 percent, and 13.70 percent, respectively. Distribution costs consist of employee-related expenses, which are the company's main operating expenses, including salaries, bonuses, entertainment/employee welfare, and commissions, which are expenses to promote sales to meet the company's targets.
In 2022, the company had distribution costs of 94.90 million baht, an increase of 1.31 million baht or 1.40 percent compared to the same period of the previous year. This was due to an increase in donation expenses of 0.93 million baht to support teaching and learning materials for students, an increase in freight costs of 1.49 million baht due to higher oil prices, an increase in packaging costs of 0.62 million baht, and a decrease in sample products of 0.14 million baht.
For 2023, the company had distribution costs of 90.64 million baht, a decrease of 4.26 million baht or 4.49 percent compared to the same period of 2022. This was due to a decrease in sales promotion expenses of 1.34 million baht due to cost control and a decrease in donation expenses of 2.91 million baht.
In 2024, the company had distribution costs of 100.07 million baht, an increase of 9.43 million baht or 10.40 percent compared to the same period of 2023. This was due to an increase in donation expenses of 2.81 million baht, an increase in sample products of 3.55 million baht, an increase in freight costs of 1.25 million baht, and an increase in labor costs for packing goods of 0.82 million baht, which correlated with the increased sales.
Administrative expenses
In 2022 – 2024, administrative expenses were 117.40 million baht, 134.60 million baht, and 144.04 million baht, respectively, or representing an administrative expense to total revenue ratio of 18.07 percent, 19.16 percent, and 19.72 percent, respectively. Administrative expenses mainly consist of salaries, bonuses, depreciation, and consulting fees, etc.
For 2022, the company had administrative expenses of 117.40 million baht, or representing an administrative expense to total revenue ratio of 18.07 percent, an increase of 9.18 million baht or 8.48 percent. The company had an increase in depreciation of 0.89 million baht from showrooms/office equipment/medical equipment for demonstration. TM Nursing Care Co., Ltd. had administrative expenses of 10.46 million baht, consisting of salaries, welfare, and employee expenses of 2.81 million baht, sales promotion consumables of 0.36 million baht, audit fees of 0.13 million baht, and professional/consulting fees of 2.47 million baht, depreciation and utilities of 3.13 million baht, interest expenses of 0.92 million baht, and other expenses of 0.64 million baht.
In 2023, the company had administrative expenses of 134.60 million baht, or representing an administrative expense to total revenue ratio of 19.16 percent, an increase of 17.20 million baht or 14.65 percent. This was due to the company renting additional warehouses, resulting in an increase in depreciation - right-of-use assets for warehouses, and an increase in depreciation of medical equipment for demonstration of 2.74 million baht. Other utilities - warehouses increased by 1.33 million baht, and travel expenses - abroad increased by 1.52 million baht due to executives traveling to trade shows to select new products. TM Nursing Care Co., Ltd. had administrative expenses of 10.46 million baht, consisting of salaries, welfare, and employee expenses of 7.39 million baht, sales promotion consumables of 3.90 million baht, audit fees of 0.17 million baht, and professional/consulting fees of 1.39 million baht.
In 2024, the company had administrative expenses of 129.10 million baht, or 17.67 percent of total revenue, a decrease of 5.50 million baht, or 4.09 percent. This was due to the company's internal cost control measures. However, the company leased additional warehouses, resulting in an increase in depreciation and amortization expenses for warehouses and an increase in depreciation expenses of 2.50 million baht. Utility expenses for warehouses increased by 0.45 million baht. The Parents Co., Ltd. had administrative expenses of 22.96 million baht, consisting of 6.05 million baht for salaries, wages, and employee benefits, 10.33 million baht for sales promotion materials, 0.15 million baht for audit fees, and 1.17 million baht for professional services/consulting fees. In 2017, the subsidiary recorded a loss on impairment of assets from discontinued operations of 14.94 million baht, or 2.05 percent.
Profit (loss) from exchange rate
In 2022-2024, the company had a profit (loss) from exchange rate of 4.69 million baht, 5.66 million baht, and 4.44 million baht, respectively, or representing 0.72 percent, 0.81 percent, and 0.61 percent of total revenue, respectively. This was due to fluctuations in foreign exchange rates from the company having to pay for medical equipment products in foreign currencies. If the economic situation causes the baht to depreciate or appreciate against foreign currencies, especially the US dollar and the euro, which are the main foreign currencies that the company uses to pay for goods to manufacturers, it will affect the company's profit (loss) from exchange rate. The company hedges against such exchange rate risk by entering into forward contracts with financial institutions. The company does not have a policy to speculate on exchange rate fluctuations.
As of December 31, 2022, December 31, 2023, and December 31, 2024, the company had forward contracts with financial institutions as follows:
Forward contract for US dollar (Unit: Million foreign currency)
December 31, 2022 - USD 0.29 (9.93 million baht)
December 31, 2023 -none-
December 31, 2024 - USD 41.00 (1.40 million baht)
In addition, the fair value of outstanding forward contracts as of December 31, 2022, December 31, 2023, and December 31, 2024, is as follows:
Forward contract for US dollar (Unit: Million baht)
December 31, 2022 - 9.85 million baht
December 31, 2023 -none-
December 31, 2024 - 1.40 million baht
As of December 31, 2022, December 31, 2023, and December 31, 2024, the company had significant monetary assets and liabilities denominated in foreign currencies that were not hedged against exchange rate risk, as follows:
Monetary assets - None-
Liabilities in foreign currencies
US dollar 2022 Amount 0.90 2023 Amount 3.47 2024 Amount 3.09
Euro 2022 Amount 0.16 2023 Amount 0.26 2024 Amount 0.14
Japanese Yen 2022 none 2023 Amount 2.21 2024 Amount 3.78
Australian dollar 2022 none 2023 Amount 0.10 2024 Amount 0.11
Chinese Yuan 2022 none 2023 Amount 0.28 2024 Amount 7.33
Swedish Krona 2022 Amount 0.40 2023 Amount 2.24 2024 Amount 1.68
Financial costs
In 2022 – 2024, the company had financial costs of 6.27 million baht, 15.58 million baht, and 19.97 million baht, respectively, or representing a financial cost to total revenue ratio of 0.97 percent, 2.22 percent, and 2.73 percent, respectively. The company's significant financial costs are interest on loans from financial institutions, such as promissory notes (P/N), trust receipts (T/R) and interest on long-term loans.
In 2022, the company had financial costs of 6.27 million baht, representing a financial expense to total revenue ratio of 0.97 percent, an increase of 1.25 million baht or 24.90 percent compared to the previous year. This was due to the parent company having an increase in trust receipt loans for importing goods to be used as working capital within the company. In addition, financial institutions have adjusted interest rates upwards, and TM Nursing Care Co., Ltd. has drawn down loans for the construction of The Parents project, resulting in higher financial costs.
For 2023, the company had financial costs of 15.58 million baht, representing a financial expense to total revenue ratio of 2.22 percent, an increase of 9.31 million baht or 148.48 percent compared to the previous year. This was due to the company having an increase in trust receipt loans for importing goods to be used as working capital within the company of 3.70 million baht. In addition, financial institutions have adjusted interest rates upwards, and TM Nursing Care Co., Ltd. has drawn down loans for the construction of The Parents project in Building B, resulting in higher financial costs of 5.60 million baht.
And in 2024, the company had financial costs of 19.97 million baht, representing a financial expense to total revenue ratio of 2.73 percent, an increase of 4.39 million baht or 28.18 percent compared to the previous year. This was due to the parent company having an increase in trust receipt loans for importing goods to be used as working capital within the company. In addition, financial institutions have adjusted interest rates upwards, and The Parents Co., Ltd. has drawn down loans for the construction of The Parents project in Building B, resulting in higher interest expenses.
Gross profit margin and net profit (loss)
In 2022 – 2024, the company had a gross profit of 228.53 million baht, 230.52 million baht, and 232.87 million baht, respectively, or representing a gross profit margin to total revenue ratio of 35.55 percent, 34.08 percent, and 32.11 percent.
In 2022, the company had a gross profit for 2022 of 228.54 million baht, a decrease of 16.82 million baht or 6.67 percent compared to the same period of the previous year. This was due to the decrease in sales volume in 2021, which was due to a decrease in sales from ATK products, resulting in a decrease in gross profit.
In 2023, the company had a gross profit from sales of 243.04 million baht, an increase of 14.50 million baht, or 6.34 percent, compared to the same period of the previous year, which correlated with the increased sales volume due to increased sales of new products such as Alcohol ball and blood bank products. The company had a gross loss from services for 2016 of 12.53 million baht, as it was the period when the subsidiary began operations.
In 2024, the company had a gross profit from sales of 241.50 million baht, a decrease of 1.54 million baht, or 0.63 percent, compared to the same period of the previous year, which correlated with the increased sales volume, but the company needed to reduce selling prices to compete with current price competition. However, the company continued to sell more new products, such as Alcohol Pad, TM Extension with T-connector, and blood bank products. The company had a gross loss from services for 2017 of 8.63 million baht, a decrease of 3.90 million baht, or 31.12 percent, compared to the same period of the previous year, due to an increase in service users and an increase in the number of traditional Chinese medicine acupuncture clinics open for service.
Considering the net profit (loss), in 2022 – 2024, the company had a net profit of 11.08 million baht, -11.92 million baht, and a net loss of -31.14 million baht, respectively, or representing a net profit margin of 1.71 percent, -1.70 percent, and -4.26 percent, respectively.
For 2022, the company had a net profit of 11.08 million baht, or representing a net profit margin to total revenue ratio of 1.71 percent, which decreased from 2021 by 18.66 million baht or 62.74 percent compared to the same period of the previous year. This was due to the profit from the sale of ATK products in 2021, which resulted from sales of 74.25 million baht, but in 2022 there were no sales And the Parents Company Limited incurred administrative expenses of 10.46 million baht. There was interest income of 1.13 million baht, service income - caregivers of 0.11 million baht, and other income of 0.26 million baht, resulting in the Parents Company Limited having a net loss of 9.44 million baht while TM having a net profit of 20.76 million baht.
In 2023, the company had a net profit (loss) of -11.92 million baht, or representing a net profit (loss) margin to total revenue ratio of -1.71 percent, which decreased from 2022 by 23.00 million baht or -207.58 percent compared to the same period of the previous year. This was due to The Parents Company Limited having a net loss of 35.13 million baht, therefore, the consolidated financial statements showed a loss compared to 2022. However, considering the company's separate financial statements, TM had a net profit of 23.97 million baht, and T M Trading Company Limited had a net profit of 1.88 million baht.
In 2024, the company had a net loss of -31.14 million baht, or representing a net loss to total revenue ratio of -4.26 percent, which was a loss increase from 2023 of 19.22 million baht or 161.24 percent compared to the same period of the previous year. This was due to the group of subsidiaries having a net loss of 47.48 million baht. Therefore, the consolidated financial statements showed a loss compared to 2023. However, considering the company's separate financial statements, the company had a net profit of 14.71 million baht, and the subsidiary (T M Trading Co., Ltd.) had a net profit of 2.80 million baht. Return on equity: the company had a return on equity for 2022, 2023, and 2024 of 2.23 percent, 2.51 percent, and -7.06 percent, respectively.
Return on equity
The company had a return on equity for 2022, 2023, and 2024 of 2.23 percent, 2.51 percent, and -7.06 percent, respectively. The return on equity in 2024 decreased from 2023 due to the company's decreased net profit from the subsidiary's net loss of 47.48 million baht.
Liquidity & Capital Adequacy
Liquidity
As of December 31, 2022, the Company had a current ratio of 1.54 times. Current assets decreased, which corresponded to a decrease in sales. At the same time, TM Nursing Care Co., Ltd. had an increase in current liabilities. There was a withdrawal of long-term loans to pay for the construction of The Parents project.
As of December 31, 2023, the Company had a current ratio of 1.39 times. Current assets increased, which corresponded to an increase in sales. At the same time, TM Nursing Care Co., Ltd. had an increase in current liabilities. There was a withdrawal of long-term loans to pay for the construction of The Parents project, resulting in a decrease in the current ratio compared to 2022.
As of December 31, 2024, the Company had a current ratio of 1.35 times. Current assets decreased slightly compared to 2023, which corresponded to The Parents Co., Ltd. having a decrease in current liabilities from the repayment of long-term loans for the construction of The Parents project, resulting in a decrease in the current ratio compared to 2023.
In addition, considering the quick ratio, as of December 31, 2022, 2023, and 2024, the Company had a quick ratio of 0.91 times, 0.75 times, and 0.73 times, respectively. In 2023 and 2024, the Company's quick ratio decreased. Considering the cash cycle, as of December 31, 2022, 2023, and 2024, the Company had a cash cycle of 208 days, 205 days, and 203 days, respectively. The Company's cash cycle was relatively long and decreased slightly in 2024 because the Company had a long collection period for receivables from government hospitals, which is normal for sales to such government hospitals. In addition, from 2022 to 2024, the Company had sales on credit terms to hospitals with an average collection period of 90-120 days for government hospitals and 30-60 days for private hospitals. The decrease in the cash cycle as of December 31, 2022-2024 was due to a slight decrease in the average collection period due to a slowdown in the turnover of trade receivables from some government hospital customers whose debt collection could be slightly increased, which had to wait for disbursement according to the budget cycle from the government, which would be in the fourth quarter of each year, and an increase in the average sales period due to the stable inventory turnover ratio from the Company's slightly decreased inventory of goods in the group of equipment and medical supplies - central supply units of hospitals and operating rooms, which had a relatively fast sales rate. In addition, the average payment period was slightly shorter. At the same time, the Company's trade payables decreased from payables for goods in the group of equipment and medical supplies - central supply units of hospitals, whose sales decreased due to the manufacturer's increase in the cost of raw materials, coupled with increased market competition, which required a slowdown in ordering goods. In addition, in some cases, payment for goods had to be made before receiving the goods.
Considering the interest coverage ratio, as of December 31, 2022, 2023, and 2024, the Company had an interest coverage ratio of 1.62 times, -0.78 times, and 0.94 times, respectively, showing that the Company's ability to pay interest increased slightly due to the decrease in the Company's cash flows from operating activities, especially in 2024 when the subsidiary had a continuous net loss, resulting in a slight increase in the interest coverage ratio.
Considering the ability to meet obligations, as of December 31, 2022, 2023, and 2024, the Company had the ability to meet obligations of 0.10 times, -0.24 times, and 1.63 times, respectively. In 2022, the Company had a positive ability to meet obligations due to positive cash flows from operating activities in 2022 from the collection of trade receivables in 2022. In 2023, the Company had a positive ability to meet obligations due to negative cash flows from operating activities as the subsidiary had a net loss. However, considering the Company's separate statement of cash flows, the Company had positive cash flows from operating activities in 2023 from the collection of trade receivables. In 2024, the Company had a positive ability to meet obligations due to positive cash flows from operating activities in 2024 from the collection of trade receivables.
Cash flows for the years ended December 31, 2022, 2023, and 2024
Net cash provided by (used in) operating activities
In 2022, the Company had cash receipts from operating activities of 15.53 million baht from the Company's profit before income tax expenses of 16.97 million baht and depreciation/amortization of 20.34 million baht. In addition, there was an increase in sales, resulting in an increase in inventories of 15.74 million baht and an increase in trade receivables of 16.26 million baht, including income tax payments of 11.64 million baht.
For 2023, the Company had cash used in operating activities of 17.82 million baht from the Company's loss before income tax expenses of 11.92 million baht. In addition, there was an increase in sales.
For 2024, the Company had cash receipts from operating activities of 53.29 million baht. This was due to the Company's efforts to manage inventory to meet demand, resulting in faster inventory turnover, coupled with increased sales and faster collection of receivables.
Net cash provided by (used in) investing activities
In 2022, the Company had cash payments from investing activities of 127.13 million baht, mainly from cash outflows from investments in property, plant and equipment of 125.89 million baht for the construction of The Parents project and an increase in intangible assets of 2.14 million baht.
For 2023, the Company had cash payments from investing activities of 52.83 million baht, mainly from cash outflows from investments in property, plant and equipment of 54.15 million baht for the construction of The Parents project and an increase in intangible assets of 0.02 million baht.
For 2024, the Company had cash receipts from investing activities of 18.46 million baht, mainly from the return of net assets of subsidiaries that decreased from the discontinuation of operations of 28.91 million baht and the subsidiary's purchase of fixed assets during the period of 8.34 million baht.
Net cash provided by (used in) financing activities
For 2022, the Company had cash flows from financing activities of 55.58 million baht due to an increase in long-term loans of 61.88 million baht and an increase in short-term loans from financial institutions of 33.75 million baht. There were also interim dividend payments during the period of 26.18 million baht.
For 2023, the Company had cash flows from financing activities of 42.97 million baht due to an increase in long-term loans of 19.97 million baht and an increase in short-term loans from financial institutions of 66.46 million baht. There were also dividend payments during the period of 15.40 million baht, interest payments of 15.83 million baht, and lease payments of 6.49 million baht.
For 2024, the Company used cash from financing activities of 99.93 million baht due to an increase in long-term loans of 11.82 million baht and an increase in short-term loans from financial institutions of 23.76 million baht. There were also interim dividend payments of 10.16 million baht, interest payments of 19.46 million baht, lease payments of 5.71 million baht, and repayments of short-term loans from related parties of 29.00 million baht.
Expenses for investment
The Company's expenses for investment in 2022, 2023, and 2024 were for investments in office building renovations, office equipment, and vehicles to support future business growth. The details of the expenses for investment are as follows:
Expenses for investment in property, plant and equipment
Year 2022, 125.89 million baht
Year 2023, 54.15 million baht
Year 2024, 10.78 million baht
Expenses for investment in subsidiaries (in the separate financial statements)
Year 2022, 5 million baht, while in 2023 and 2024 there were no items.
Asset Management Capability
Assets
As of December 31, 2022, 2023, and 2024, the Company had total assets of 929.76 million baht, 983.34 million baht, and 908.17 million baht, respectively. The following are the significant assets that affected the changes in the Company's total assets:
Current assets
As of December 31, 2022, 2023, and 2024, the Company had total current assets of 514.52 million baht, 545.91 million baht, and 497.39 million baht, respectively, representing 55.34%, 55.52%, and 54.77% of total assets, respectively. The details of each significant item are as follows:
- Cash and cash equivalents : As of December 31, 2022, 2023, and 2024, the amount was 100.07 million baht, 72.39 million baht, and 44.22 million baht, respectively, representing 10.76%, 7.36%, and 4.87% of total assets, respectively. As of December 31, 2024, cash and cash equivalents decreased from December 31, 2023 by 28.17 million baht, or 38.91%. The main reason for the decrease in cash and cash equivalents was due to the purchase of fixed assets during the period by the Company and its subsidiary totaling 8.34 million baht, which were fixed assets in the group of medical equipment and supplies. The subsidiary returned net assets from the liquidation of 28.91 million baht and paid long-term loans, net during the period of 11.82 million baht, including interest payments of 19.46 million baht and dividend payments of 10.16 million baht.
- Trade receivables : As of December 31, 2022, 2023, and 2024, the amount was 203.47 million baht, 220.93 million baht, and 224.81 million baht, respectively, representing 21.88%, 22.47%, and 24.75% of total assets, respectively.
Comparing trade receivables as of December 31, 2021 and 2022, the Company's trade receivables increased by 8.51 million baht, or 4.36%, from 2021. This increase was due to an increase in sales of equipment and consumables-operating room of 36.18 million baht. However, the Company was still able to collect more overdue receivables. The Company recognized a loss (reversal of loss) on impairment of financial assets (allowance for doubtful accounts) of 0.14 million baht.
Comparing trade receivables as of December 31, 2022 and 2023, the Company's trade receivables increased by 17.46 million baht or 8.58% from 2022. This increase was due to an increase in sales of equipment and consumables - operating room of 49.56 million baht and equipment and consumables - laboratory and blood bank of 20.82 million baht. However, the Company was still able to collect more outstanding debts. The Company recognized a reversal of impairment loss on financial assets (allowance for doubtful accounts) of 0.29 million baht.
Comparing trade receivables as of December 31, 2023 and 2024, the Company's trade receivables increased by 3.88 million baht, or 1.76%, from 2023. This increase was due to an increase in sales of equipment and consumables-operating room of 28.78 million baht and an increase in sales of equipment and consumables-laboratory and blood bank of 1.50 million baht. However, the Company was still able to collect more overdue receivables. The Company recognized a loss (reversal of loss) on impairment of financial assets (allowance for doubtful accounts) of 0.37 million baht.
The Company's trade receivables consist of trade receivables and advances from customers. The Company has a policy of granting credit terms to different types of customers as follows:
Government hospitals 90 days
Private hospitals 60 – 90 days
Clinics and medical personnel Cash or 30 days
The Company's policy for determining the allowance for expected credit losses (allowance for doubtful accounts) is to provide a full allowance for receivables overdue for more than 12 months and to calculate the allowance in accordance with Thai Financial Reporting Standards No. 9 (TFRS 9), which is a standard on financial instruments whose primary objective is to provide financial reporting for financial assets and financial liabilities and to reflect credit losses.
However, based on the historical payment history in 2022-2024, the Company has not had any significant bad debts from collecting receivables from customers. This is because the Company's customers are mainly government and private hospitals and medical facilities that have a good payment history. The Company has never experienced any problems with uncollectible receivables. In addition, the Company has a policy of collecting receivables from customers through its sales representatives. The Company's sales representatives are fully responsible for collecting payments from customers in their respective teams.
During 2022-2024, the Company had an average collection period of 112 days, 110 days, and 112 days, respectively.
As of December 31, 2022, the majority of trade receivables remained non-due, with a value of 137.68 million baht, or 67.34% of total receivables, and overdue receivables of 66.77 million baht, or 32.66%. However, trade receivables overdue for more than 12 months, amounting to 0.66 million baht, or 0.32%, are receivables from government hospitals or medical facilities, which have the ability and efficiency to pay, but are unable to pay on time due to the need to wait for government budget support. The Company expects to be able to collect all receivables and there is no risk of uncollectible receivables, and has recorded an allowance for doubtful accounts of 0.90 million baht in 2022.
As of December 31, 2023, the majority of trade receivables remained non-due, with a value of 145.11 million baht, or 65.60% of total receivables, and overdue receivables of 76.11 million baht, or 34.40%. However, trade receivables overdue for more than 12 months, amounting to 0.92 million baht, or 0.42%, are receivables from government hospitals or medical facilities, which have the ability and efficiency to pay, but are unable to pay on time due to the need to wait for government budget support. The Company expects to be able to collect all receivables and there is no risk of uncollectible receivables, and has recorded an allowance for doubtful accounts of 0.29 million baht in 2023.
As of December 31, 2024, the majority of trade receivables remained non-due, with a value of 151.17 million baht, or 67.05% of total receivables, and overdue receivables of 74.30 million baht, or 32.95%. However, trade receivables overdue for more than 12 months, amounting to 0.49 million baht, or 0.49%, are receivables from government hospitals or medical facilities, which have the ability and efficiency to pay, but are unable to pay on time due to the need to wait for government budget support. The Company expects to be able to collect all receivables and there is no risk of uncollectible receivables, and has recorded an allowance for doubtful accounts of 0.66 million baht in 2024.
- Inventories : As of December 31, 2022, 2023, and 2024, the carrying amount was 177.73 million baht, 221.72 million baht, and 186.34 million baht, representing 19.12%, 22.55%, and 20.52% of total assets, respectively.
Comparing inventories as of December 31, 2023 and 2024, the Company's inventories decreased by 35.38 million baht, or 15.96%, in line with sales. This was due to the fact that in 2024, the demand for products in the equipment and consumables-operating room group increased as hospitals resumed normal surgical services. The Company has tried to reduce inventory levels in order to increase inventory turnover and has had to order goods to meet customer demand.
The majority of inventories are goods held for sale and goods in transit. As the Company is in the business of selling medical instruments and equipment, it is necessary to purchase goods to meet customer demand and to consider the lead time for delivery. The Company manages the ordering and delivery of goods to customers on time due to its long experience in the business and its efficient planning and ordering. Goods in transit are goods that are in the process of being shipped and have various forms of shipping, such as EXW (Ex Works), FOB (Free On Board), FCA (Free Carrier), CIF (Cost, Insurance & Freight), and CIP (Carriage and Insurance Paid).
Considering the average sales period in 2022-2024, the Company had an average sales period of 154 days, 154 days, and 149 days, respectively. This is because the Company imports all of its medical instruments and equipment from abroad, so it must plan its purchases and maintain a variety of inventory to meet customer demand.
The Company provides an allowance for obsolete/impaired inventories based on the age of the inventories. The Company has a policy of providing an allowance for obsolete inventories based on inventories that have not been rotated for more than one year or are nearing their expiry date (within 6 months). If such inventories are found to be nearing their expiry date, obsolete, or impaired, the Company will recognize an impairment loss, which is charged to profit or loss, and an allowance for obsolete inventories to reduce the carrying amount of inventories. The Company started to provide an allowance for obsolete and expired inventories as of December 31, 2022, with an allowance of 8.10 million baht. As of December 31, 2023, and December 31, 2024, the allowance for obsolete and expired inventories was 10.55 million baht and 12.63 million baht, respectively.
-Other receivables : As of December 31, 2021, 2022, and 2023, the Company had other receivables of Baht 33.25 million, Baht 30.87 million, and Baht 42.02 million, respectively, representing 3.58%, 3.14%, and 4.63% of total assets, respectively. These mainly comprised value-added tax and purchase tax payable, and prepaid expenses for goods.
As of December 31, 2021, the Company had an increase in other receivables of Baht 14.16 million, or an increase of 74.17% compared to December 31, 2020. The increase in other receivables consisted of value-added tax and purchase tax payable, a decrease in employee advances, a decrease in prepaid expenses for goods, and at the same time, an increase in other receivables from The Parents Co., Ltd. of Baht 9.23 million, consisting of value-added tax receivables from the construction of the building of Baht 8.40 million and prepaid expenses of Baht 0.35 million.
Meanwhile, as of December 31, 2022, the Company had a decrease in other receivables of Baht 2.38 million, or a decrease of 7.16% compared to December 31, 2021. The increase in other receivables consisted of value-added tax and purchase tax payable, a decrease in employee advances, a decrease in prepaid expenses for goods, and at the same time, an increase in other receivables from The Parents Co., Ltd. of Baht 2.33 million, consisting of value-added tax receivables from the construction of the building that have not yet been claimed.
And as of December 31, 2023, the Company had an increase in other receivables of Baht 11.15 million, or an increase of 36.12% compared to December 31, 2022. The increase in other receivables consisted of value-added tax and purchase tax payable, employee advances, and prepaid expenses for goods.
Bank deposits with guarantee: As of December 31, 2022, 2023, and 2024, the Company had bank deposits with Guarantees of 8.00 million baht, 8.00 million baht, and 8.00 million baht, respectively, representing 0.86%, 0.81%, and 0.88% of total assets, respectively, for guarantees with one bank. These deposits serve as collateral to a bank for the Company's credit line.
Property, plant and equipment-net : As of December 31, 2022, 2023, and 2024, the Company had property, plant and equipment-net of 383.85 million baht, 405.45 million baht, and 378.69 million baht, respectively, representing 41.29%, 41.23%, and 41.70% of total assets, respectively.
A comparison of property, plant and equipment in 2022 and 2023 showed an increase in the value of property, plant and equipment of 120.55 million baht, or 45.78%, due to an increase in medical equipment/instruments for demonstration of 6.41 million baht, an increase in office equipment/computer equipment/furniture of 1.83 million baht, an increase in vehicles of 2.26 million baht, and depreciation of 26.60 million baht. In 2023, buildings and building improvements, and equipment-net of TM Nursing Care Co., Ltd. increased by 37.45 million baht, consisting of the construction of buildings, land improvements, and fixed assets for the The Parents project, and medical instruments and equipment of 9.98 million baht.
A comparison of property, plant and equipment in 2023 and 2024 showed a decrease in the value of property, plant and equipment of 26.76 million baht, or 6.60%, due to an increase in medical equipment/instruments for demonstration of 7.24 million baht, an increase in office equipment/furniture of 1.17 million baht, an increase in computer equipment of 0.16 million baht, and depreciation of 17.32 million baht. In 2024, buildings and building improvements, and equipment-net of The Parents Company Limited increased by 6.64 million baht, consisting of the construction of buildings, land improvements, and fixed assets for the The Parents project. The subsidiary recorded accumulated depreciation of 11.58 million baht. In the third quarter of 2024, the subsidiary PH was approved for liquidation, resulting in a loss from impairment or disposal of 14.94 million baht.
Liabilities
As of December 31, 2022, 2023, and 2024, the Company had total liabilities of 441.00 million baht, 521.90 million baht, and 488.04 million baht, respectively, representing 47.43%, 53.07%, and 53.74% of total liabilities and shareholders' equity, respectively. The debt-to-equity ratio in the past was 0.90 times, 1.13 times, and 1.16 times, respectively. The following are the significant changes in liabilities:
Current liabilities
As of December 31, 2022, 2023, and 2024, the Company had total current liabilities of 334.71 million baht, 392.94 million baht, and 367.13 million baht, respectively, representing 36.00%, 39.96%, and 40.43% of total liabilities and shareholders' equity, respectively. The details of each significant item are as follows:
-Bank overdrafts and short-term loans from financial institutions : As of December 31, 2022, 2023, and 2024, the amount was 194.83 million baht, 257.98 million baht, and 234.05 million baht, respectively, representing 20.96%, 26.24%, and 25.77% of total liabilities and shareholders' equity, respectively. Short-term loans from financial institutions are in the form of promissory notes and loans under trust receipt agreements. Promissory notes with a maturity of not more than 365 days have an interest rate per annum equal to MMR. Loans under trust receipt agreements (maturing within 3-6 months) have an interest rate per annum equal to MMR. The credit line is used to pay for goods and for working capital.
As of December 31, 2022, the Company had promissory notes payable of 21.14 million baht, due to payments made during the year when the promissory notes matured, and loans under trust receipt agreements of 173.69 million baht, an increase of 54.99 million baht from 2021. The loans under trust receipt agreements are revolving loans used in the normal course of business.
As of December 31, 2023, the Company had promissory notes payable of 70.00 million baht, due to payments made during the year when the promissory notes matured, and loans under trust receipt agreements of 187.98 million baht, an increase of 14.29 million baht from 2022. The loans under trust receipt agreements are revolving loans used in the normal course of business.
As of December 31, 2024, the Company had promissory notes payable of 105.00 million baht, due to payments made during the year when the promissory notes matured, and loans under trust receipt agreements of 129.05 million baht, a decrease of 58.93 million baht from 2023. The loans under trust receipt agreements are revolving loans used in the normal course of business.
-Trade payables : As of December 31, 2022, 2023, and 2024, the amount was 74.73 million baht, 80.75 million baht, and 83.74 million baht, respectively, representing 8.04%, 8.21%, and 9.22% of total liabilities and shareholders' equity, respectively. In 2024, the Company's trade payables increased by 2.99 million baht, or 3.70%, compared to December 31, 2023, due to an increase in orders in the fourth quarter of 2024, which was in line with sales volume in order to reserve sufficient inventory to meet demand. The Company receives credit terms from trade creditors of approximately 60-90 days, depending on the payment terms of each trade creditor. In 2024, the payment of trade payables was due, resulting in a decrease in trade payables. The average payment period in 2022-2024 was 59 days, 60 days, and 61 days, respectively.
-Other payables : As of December 31, 2022, 2023, and 2024, the Company had other payables of 43.97 million baht, 36.15 million baht, and 29.92 million baht, respectively, representing 4.73%, 3.68%, and 3.29% of total liabilities and shareholders' equity, respectively. These consisted of accrued employee bonuses, accrued commissions, accrued withholding tax, accrued social security, and accrued provident fund contributions. In 2022, other payables increased by 5.65 million baht, or 14.74%, from the balance as of December 31, 2021, due to
an increase in the payment for the construction of buildings of the Parents Company Limited of 5.60 million baht. In 2023, the Company's accrued expenses and other current liabilities decreased by 7.82 million baht, or 17.78%, from the balance as of December 31, 2022, due to the transfer of advances from customers to sales revenue, resulting in a decrease in advances from customers of 2.13 million baht in 2023, and a decrease in accrued expenses and deductions from receipts of 0.44 million baht. The subsidiary paid other payables of 0.25 million baht. In 2024, the Company's accrued expenses and other current liabilities decreased by 6.23 million baht, or 17.23%, from the balance as of December 31, 2023, due to the payment of bonuses for the year 2023 of 8.00 million baht.
Non-current liabilities
As of December 31, 2022, 2023, and 2024, the Company had total non-current liabilities of 106.29 million baht, 128.96 million baht, and 120.91 million baht, respectively, representing 11.43%, 13.11%, and 13.31% of total liabilities and shareholders' equity, respectively. The significant changes in non-current liabilities are as follows:
- Long-term loans : As of December 31, 2022, 2023, and 2024, the Company had long-term loan obligations of 88.42 million baht, 105.60 million baht, and 94.26 million baht, respectively, representing 9.51%, 10.74%, and 10.38% of total liabilities and shareholders' equity, respectively. In 2023, The Parents Company Limited drew down a long-term loan for the construction of a building in the amount of 105.60 million baht (from a credit line of 230 million baht). In 2024, The Parents Company Limited repaid long-term loans of 11.82 million baht.
-Employee benefit liabilities : As of December 31, 2022, 2023, and 2024, the Company had employee benefit liabilities of 14.19 million baht, 17.28 million baht, and 19.85 million baht, respectively, representing 1.53%, 1.76%, and 2.57% of total liabilities and shareholders' equity, respectively. The Company has an obligation to pay severance pay to employees upon termination of employment under the Labor Protection Act. The Company considers such severance pay to be a post-employment benefit plan for employees. The liability for the employee post-employment benefit plan is calculated using the projected unit credit method. An independent actuary has valued the obligation in accordance with actuarial principles. As of December 31, 2024, the Company had employee benefit liabilities of 19.85 million baht, an increase of 2.57 million baht, or 14.87%, due to the recalculation of employee pension reserves every 3 years by an actuary. The Company recorded an increase in employee pension reserves during the year of 3.12 million baht and paid employee pension benefits of 0.75 million baht. In 2023, the subsidiary considered recording an increase in employee pension reserves in the third quarter of 2023, and in 2024, it recorded an increase in employee pension reserves of 1.80 million baht.
Shareholders' equity
As of December 31, 2022, 2023, and 2024, the Company had total shareholders' equity of 488.75 million baht, 461.43 million baht, and 420.13 million baht, respectively, representing 52.57%, 46.93%, and 46.26% of total liabilities and shareholders' equity, respectively. The following are the significant changes in shareholders' equity:
- Issued and paid-up capital : As of December 31, 2022, the Company had a registered capital of 205.33 million baht, consisting of 410,666,649 ordinary shares in 2022 and 308,000,000 ordinary shares in 2021, with a par value of 0.50 baht per share, and issued and fully paid-up capital consisting of 307,999,987 ordinary shares with a par value of 0.50 baht per share (changed from December 31, 2021, by issuing 102,666,662 new ordinary shares at a par value of 0.50 baht per share for a total of 51,333,331 baht to support the exercise of warrants to purchase ordinary shares issued to existing shareholders).
As of December 31, 2023, the Company had a registered capital of 205.33 million baht, consisting of 410,666,649 ordinary shares in 2022 and 308,000,000 ordinary shares in 2021, with a par value of 0.50 baht per share, and issued and fully paid-up capital consisting of 307,999,987 ordinary shares with a par value of 0.50 baht per share (unchanged from December 31, 2023)
As of December 31, 2024, the Company had a registered capital of 205.33 million baht, consisting of 410,666,649 ordinary shares in 2022 and 308,000,000 ordinary shares in 2021, with a par value of 0.50 baht per share, and issued and fully paid-up capital consisting of 307,999,987 ordinary shares with a par value of 0.50 baht per share (unchanged from December 31, 2024).
-Share premium : As of December 31, 2022, 2023, and 2024, the Company had share premium of 184.03 million baht (net of offering expenses of 15.97 million baht), representing 19.79%, 18.71%, and 20.26% of total liabilities and shareholders' equity, respectively.
-Statutory reserve : As of December 31, 2022, 2023, and 2024, the amount was 16.44 million baht, 17.64 million baht, and 18.38 million baht, respectively. This is a reserve under the provisions of the Civil and Commercial Code. The Company is required to appropriate to the reserve at least 5% of its net profit for the year each time a dividend is declared until the reserve reaches 10% of the Company's registered capital. This reserve cannot be used to pay dividends. However, in 2024, the Company appropriated an additional 0.74 million baht to the reserve.
-Retained earnings-unappropriated : As of December 31, 2022, 2023, and 2024, the Company had unappropriated retained earnings of 77.11 million baht, 56.02 million baht, and 23.48 million baht, respectively, representing 8.29%, 5.70%, and 2.59% of total liabilities and shareholders' equity, respectively. The decrease in retained earnings was due to the net profit from the Company's operations in each year, net of dividend payments and appropriations to statutory reserves. The subsidiary's net loss also contributed to the decrease in unappropriated retained earnings.
In 2022, the Company had unappropriated retained earnings of 77.11 million baht, a decrease of 16.69 million baht, or 17.79%, compared to unappropriated retained earnings as of December 31, 2021, due to the payment of dividends of 26.18 million baht and the appropriation of profit to statutory reserves of 1.04 million baht. Meanwhile, the Company had profit for the year attributable to owners of the parent of 10.53 million baht in 2022, resulting in a decrease in the Company's retained earnings compared to 2021. In 2022, the subsidiary had a net loss of 9.52 million baht.
In 2023, the Company had unappropriated retained earnings of 56.02 million baht, a decrease of 21.09 million baht, or 27.35%, compared to unappropriated retained earnings as of December 31, 2022, due to the payment of dividends of 15.40 million baht and the appropriation of profit to statutory reserves of 1.20 million baht. Meanwhile, the Company had a loss for the year attributable to owners of the parent of 4.49 million baht in 2023, resulting in a decrease in the Company's retained earnings compared to 2022. In 2023, the subsidiary had a net loss of 35.13 million baht.
In 2024, the Company had unappropriated retained earnings of 23.48 million baht, a decrease of 32.54 million baht or 58.09% compared to unappropriated retained earnings as of December 31, 2023, due to the payment of dividends of 10.16 million baht and the appropriation of profit to statutory reserves of 0.74 million baht. Meanwhile, the Company had a total comprehensive loss attributable to owners of the parent for 2024 of 21.64 million baht, resulting in a decrease in the Company's retained earnings compared to 2023. In 2024, the subsidiary had a net loss of 47.48 million baht.
Financial structure ratio
The Company had a debt-to-equity ratio as of December 31, 2022, 2023, and 2024 of 0.90 times, 1.13 times, and 1.16 times, respectively. The Company's debt-to-equity ratio increased due to increased borrowings from financial institutions to purchase goods and construction costs for The Parents project.
Debt Securities with Financial Ratio Requirements
Debt Securities with Financial Ratio Requirements Issued?
No
Factors That May Affect Financial Condition
Factors or Incidents That May Materially Affect Financial Condition
Most of the products sold by the company are imported from abroad. The quotation and payment for these products are primarily in US dollars. Meanwhile, products sold domestically are transacted entirely in Thai Baht. When the Baht depreciates against the US dollar, the amount the company has to pay for goods increases, which may affect the cost of goods sold for the company. Conversely, if the Baht appreciates, it may result in a lower cost of goods for the company and could also lead to gains (losses) from the exchange rate fluctuations.
However, the company enters into forward contracts for every import of goods from abroad. This allows the company to determine the cost of goods sold and hedge against exchange rate volatility that could impact the company's operating results. Entering into forward contracts is at the discretion of the company's management and is in accordance with the authorization manual approved by the Board of Directors.
The company places importance on exchange rates and has established measures to closely monitor and assess exchange rate risk situations. This includes tracking trends and movements in foreign exchange rates, analyzing economic news and data, and forecasting the trend of the Baht against major foreign currencies.

